指南与共识心脑血管急症重症综合管理与镇静镇痛

急性心力衰竭中的室性心律失常:ACVC、EHRA 与 HFA 的临床共识声明

Ventricular arrhythmias in acute heart failure. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), the European Heart Rhythm Association (EHRA) and the Heart Failure Association (HFA) of the ESC.
指南 / 共识 · Eur J Heart Fail · 2025-03-19
一句话结论急性心衰(含心源性休克)患者新发室性心律失常与院内及60天发病率和死亡率升高相关,本共识聚焦其识别与治疗。

本共识由欧洲心脏病学会(ESC)下属急性心血管护理协会(ACVC)、欧洲心律协会(EHRA)和心力衰竭协会(HFA)联合发布,针对急性心力衰竭(AHF)患者中室性心律失常(VAs)的识别与治疗。AHF期间功能性基质不稳定和调制因素增加,叠加结构性基质,使VAs风险升高;新发VAs此前已被识别与较高的院内和60天发病率及死亡率相关。风险分层、冠状动脉介入和植入式心律转复除颤器植入的标准/最佳时机在该临床情境下仍存争议。欧洲各地院前急救医学特征与物流、以及能处理AHF和VAs的中心密度差异巨大;科学指南对慢性心衰患者心律失常管理有明确推荐,但AHF患者心律失常的发生率、意义和管理研究较少。

要点

  • AHF(含心源性休克)患者新发VAs与较高的院内和60天发病率及死亡率相关。
  • AHF期间功能性基质不稳定和调制因素叠加结构性基质,增加VAs风险。
  • 风险分层、冠状动脉介入和ICD植入的标准/最佳时机在该临床情境下仍存争议。
  • 欧洲各地院前急救医学特征与物流、能处理AHF和VAs的中心密度差异巨大。
  • 科学指南对慢性心衰患者心律失常管理有明确推荐,但AHF患者心律失常研究较少。

适用人群与场景

  • 因急性心力衰竭(AHF)就诊或触发急救网络的患者,包括心源性休克患者。

研究设计与关键结果

  • 本共识由ESC下属ACVC、EHRA和HFA联合制定,旨在解决AHF(含心源性休克)病程中并发VAs的识别与治疗。
  • AHF期间新发VAs此前已被识别与较高的院内和60天发病率及死亡率相关。
  • 风险分层、冠状动脉介入和ICD植入的标准/最佳时机在该临床情境下仍存争议。
  • 欧洲各地院前急救医学特征与物流、以及能处理AHF和VAs的中心密度差异巨大。
  • 科学指南对慢性心衰患者心律失常管理有明确推荐,但AHF患者心律失常的发生率、意义和管理研究较少。

证据类型、等级与局限

  • 证据类型:临床共识声明;制定机构:ESC下属ACVC、EHRA和HFA。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

指南或共识出处

  • Ventricular arrhythmias in acute heart failure. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), the European Heart Rhythm Association (EHRA) and the Heart Failure Association (HFA) of the ESC;发布机构:ACVC、EHRA、HFA;发表于Eur J Heart Fail。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Patients presenting with or alerting emergency networks due to acute heart failure (AHF) form a diverse group with a plethora of symptoms, risks, comorbidities, and aetiologies. During AHF, there is an increased risk of destabilizing the functional substrate and modulatory adding to the risk of ventricular arrhythmias (VAs) already created by the structural substrate. New VAs during AHF have previously identified patients with higher in-hospital and 60-day morbidity and mortality. Risk stratification and criteria/best time point for coronary intervention and implantable cardioverter-defibrillator implantation, however, are still controversial topics in this difficult clinical setting. The characteristics and logistics of pre-hospital emergency medicine, as well as the density of centres capable of treating AHF and VAs, differ massively throughout Europe. Scientific guidelines provide clear recommendations for the management of arrhythmias in chronic heart failure patients. However, the incidence, significance, and management of arrhythmias in patients with AHF have been less studied. This consensus paper aimed to address the identification and treatment of VAs that complicate the course of patients who have AHF, including cardiogenic shock.

来源:Eur J Heart Fail,查看原文。版权归原作者所有。

参考来源

  1. Gorenek B, Wijnmaalen AP, Goette A, et al. Ventricular arrhythmias in acute heart failure. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), the European Heart Rhythm Association (EHRA) and the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2025. PMID: 40107728. doi:10.1002/ejhf.3645

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。